PROT - Proteonomix, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Proteonomix, Inc.

145 Highview Terrace
Hawthorne, NJ 07506
United States
973-949-4193
http://www.proteonomix.com

Sector
Industry
Full Time Employees

Key Executives

NameTitlePayExercisedAge
Mr. Michael CohenFounder, Chairman, Chief Exec. Officer, Pres and Chief Operating Officer365kN/A50
Mr. Steven Byle J.D.Chief Technology Officer and DirectorN/AN/A49
Mr. Jason B. IsaacsSec.N/AN/A45
Ms. Jaci MandilChief Exec. Officer of ProteodermN/AN/AN/A
Amounts are as of December 31, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company’s products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.

Corporate Governance

Proteonomix, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.